SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE4

Conditions

Chronic Hepatitis B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Prince of Wales Hospital, Hong Kong, Hong Kong
Contact: Study coordinator (Angel ML Chim, MSc) · angelchim@cuhk.edu.hk · 26324205
Contact: Study coordinator (Grace LH Wong, MD) · wonglaihung@cuhk.edu.hk · +85235053538

Study leads

Grace LH Wong, MD
Principal Investigator
Chinese University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis b

Abroad (travel likely)RecruitingPHASE4

Chongqing, China

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Hepatitis B · Viral Hepatitis

Abroad (travel likely)RecruitingPHASE4

Taichung, Taiwan

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Cancer · Liver Cirrhosis · Chronic Hepatitis

Abroad (travel likely)Recruiting

Redondo Beach, United States · Coon Rapids, United States